Luxembourg Authorities Find Majority of E-Cigarette Products Non-Compliant

Aug.01.2024
Luxembourg Authorities Find Majority of E-Cigarette Products Non-Compliant
Luxembourg environmental agency finds majority of e-cigarette and e-liquid samples fail to comply with tobacco laws, unregistered for sale.

According to RTL on July 31st, the Luxembourg Environmental Administration (Dé Lëtzebuerger Ëmweltverwaltung, abbreviated as AEV) conducted inspections on 45 e-cigarette and e-liquid samples. Out of the 45 samples, 86% of the products (39) did not comply with Luxembourg's tobacco laws and were not registered, and therefore cannot be sold on the Luxembourg market.


These products were purchased from 11 locations, including specialty stores, gas stations, and tobacco shops, with a focus on inspecting labels and packaging. AEV specifically checked whether the packaging had necessary child safety measures and general warning signs.


Investigation data shows that labels of 27 products are not clear enough. 20 products are in violation of regulations, with issues such as missing icons, warning signs, and danger labels. Some labels lack German or French language markings. The parties involved have been requested to voluntarily make improvements.


In addition, AEV also tested the chemical components of 13 disposable e-cigarettes, and the investigation results showed that all products complied with regulations and did not exceed the allowable limits.


AVE reminds that after disposable e-cigarettes are used, they become electronic waste and must be recycled by Ecotrel company. They should not be casually thrown into black garbage bins or the natural environment.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
German Federal Council calls for ban on disposable vape, government resists change
German Federal Council calls for ban on disposable vape, government resists change
Germany's Federal Council calls for ban on disposable e-cigarettes due to environmental and economic threats, sparking debate.
Oct.14 by 2FIRSTS.ai
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.
Oct.15
Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List
Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List
DTI plans nationwide ban on open system pods and unlicensed e-liquids to ensure consumer safety and health.
Oct.21 by 2FIRSTS.ai
Vietnam’s Health Ministry Proposes Including E-Cigarettes and Heated Tobacco in the Investment Law Ban List
Vietnam’s Health Ministry Proposes Including E-Cigarettes and Heated Tobacco in the Investment Law Ban List
Vietnam’s Ministry of Health has submitted a proposal to the Government Office recommending that “e-cigarettes and heated tobacco products” be added to the list of prohibited investment and business sectors in the amended Investment Law. The proposal aligns with National Assembly Resolution No. 173/2024/QH15, which bans the production, trade, import, and use of these products starting in 2025.
Nov.12 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai